Filing Details

Accession Number:
0001494650-18-000091
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-15 14:36:10
Reporting Period:
2018-08-15
Accepted Time:
2018-08-15 14:36:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1494650 Optinose Inc. OPTN Pharmaceutical Preparations (2834) 421771610
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639012 Edward Thomas Gibbs C/O Optinose, Inc.
1020 Stony Hill Road, Suite 300
Yardley PA 19067
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-15 2,000 $12.69 3,985 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 1,985 shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on June 29, 2018 in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).